|
Gomez-Murcia V, Carvalho K, Thiroux B, Caillierez R, Besegher M, Sergeant N, Buee L, Faivre E, Blum D. Impact of chronic doxycycline treatment in the APP/PS1 mouse model of Alzheimer's disease. Neuropharmacology. 2022 May 15;209:108999. doi: 10.1016/j.neuropharm.2022.108999. Epub 2022 Feb 15. PubMed PMID: 35181375.
AÑO: 2022; IF: 4.7
|
35181375
|
Ausili A, Gomez-Murcia V, Candel AM, Beltran A, Torrecillas A, He L, Jiang Y, Zhang S, Teruel JA, Gomez-Fernandez JC. A comparison of the location in membranes of curcumin and curcumin-derived bivalent compounds with potential neuroprotective capacity for Alzheimer's disease. Colloids Surf B Biointerfaces. 2021 Mar;199:111525. doi: 10.1016/j.colsurfb.2020.111525. Epub 2020 Dec 13. PubMed PMID: 33373844; PubMed Central PMCID: PMC7965246.
AÑO: 2021; IF: 5.999
|
|
Navarro-Zaragoza J, Martinez-Laorden E, Teruel-Fernandez FJ, Gomez-Murcia V, Canovas A, Milanes MV, Laorden ML, Almela P. Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL/6J morphine-dependent mice than in Swiss: Role of HPA axis. Pharmacol Biochem Behav. 2021 Feb;201:173106. doi: 10.1016/j.pbb.2021.173106. Epub 2021 Jan 12. PubMed PMID: 33444599.
AÑO: 2021; IF: 3.697
|
|
Brigas HC, Ribeiro M, Coelho JE, Gomes R, Gomez-Murcia V, Carvalho K, Faivre E, Costa-Pereira S, Darrigues J, de Almeida AA, Buee L, Dunot J, Marie H, Pousinha PA, Blum D, Silva-Santos B, Lopes LV, Ribot JC. IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's disease. Cell Rep. 2021 Aug 31;36(9):109574. doi: 10.1016/j.celrep.2021.109574. PubMed PMID: 34469732.
AÑO: 2021; IF: 9.995
|
|
Gomez-Murcia V, Sandau U, Ferry B, Parrot S, Laurent C, Basquin M, Buee L, Boison D, Blum D. Hyperexcitability and seizures in the THY-Tau22 mouse model of tauopathy. Neurobiol Aging. 2020 Oct;94:265-270. doi: 10.1016/j.neurobiolaging.2020.06.004. Epub 2020 Jun 20. PubMed PMID: 32679397; PubMed Central PMCID: PMC7483348.
AÑO: 2020; IF: 5.133
|